PDT Partners’s Encompass Health EHC Stock Holding History

PDT Partners’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,396	Closed	-$2.34M	–	589
2025 Q3	$2.34M	Buy	+18,396	New	+$2.19M	0.15%	231
2024 Q1	–	Sell	-25,981	Closed	-$1.73M	–	645
2023 Q4	$1.73M	Buy	25,981 +18,533	+249%	+$1.2M	0.19%	183
2023 Q3	$500K	Buy	+7,448	New	+$512K	0.06%	413
2022 Q2	–	Sell	-8,505	Closed	-$481K	–	1009
2022 Q1	$481K	Buy	8,505 +963	+13%	+$50.3K	0.04%	597
2021 Q4	$392K	Buy	+7,542	New	+$389K	0.03%	602
2021 Q3	–	Sell	-5,693	Closed	-$353K	–	809
2021 Q2	$353K	Buy	+5,693	New	+$379K	0.02%	589
2014 Q4	–	Sell	-45,772	Closed	-$1.34M	–	757
2014 Q3	$1.34M	Buy	45,772 +2,470	+6%	+$75.3K	0.03%	536
2014 Q2	$1.24M	Buy	+43,302	New	+$1.21M	0.03%	621
2013 Q4	–	Sell	-27,567	Closed	-$756K	–	766
2013 Q3	$756K	Buy	27,567 +2,893	+12%	+$74.3K	0.02%	878
2013 Q2	$565K	Buy	+24,674	New	+$558K	0.01%	1015

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PDT Partners's EHC Position: Q4 2025 in Review

PDT Partners sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 18,396 shares — an estimated $2.34M sold.

PDT Partners first reported a position in EHC in Q2 2013 and held it in 10 quarters. The position peaked at $2.34M in Q3 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

PDT Partners reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
PDT Partners sold 18,396 Encompass Health shares in Q4 2025, an estimated $2.34M.
PDT Partners first reported a position in Encompass Health in Q2 2013 and held it in 10 quarters.
PDT Partners's Encompass Health position peaked at $2.34M in Q3 2025.
594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on PDT Partners's 13F filing for Q4 2025, filed 17 Feb 2026.